Publication | Closed Access

The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee

Anti-inflammatoryMedicineChronic Musculoskeletal ConditionOsteoarthritisPharmacotherapyPharmacologyOrthopaedic SurgeryInflammatory Arthritis